About Origin Biomarkers
Origin Biomarkers Ltd was founded in 2008 in England, UK and moved to Scotland in 2013.
The company has developed several novel medical diagnostic blood tests for the detection of pregnancy disorders at the first trimester, and for the prediction of success in fertility treatment (IVF). The work was supported by R&D grants in England (APOC & AWM) and Scotland (Scottish Enterprise SMART award).
EPO and USA patents are granted for the use of these biomarkers and the company now seeks licensing partners for the commercialisation of its technologies.
Origin Biomarkers also offers an in-house service for the analysis of pre-treatment IVF patients’ blood serum as an aid to tailoring treatment plans and improving IVF pregnancy rates. Depending on the number of samples required to be tested, the price for this in-house service is negotiable.
Established October 2008
History in innovating in medical diagnostic tests
Advanced medical diagnostic tests
Unique biomarker testing for early detection for pregnancy related conditions
Patents granted (USA & EPO) for diagnostic and therapeutic applications of soluble LHCGR protein.